Next Article in Journal
The Number Needed to Immunize (NNI) to Assess the Benefit of a Prophylaxis Intervention with Monoclonal Antibodies Against RSV
Previous Article in Journal
Challenges to the Effectiveness and Immunogenicity of COVID-19 Vaccines: A Narrative Review with a Systematic Approach
Previous Article in Special Issue
Engaging Broader Stakeholders to Accelerate Group A Streptococcus Vaccine Development
 
 
Article

Article Versions Notes

Vaccines 2025, 13(8), 790; https://doi.org/10.3390/vaccines13080790
Action Date Notes Link
article pdf uploaded. 25 July 2025 16:31 CEST Version of Record -
article pdf uploaded. 25 July 2025 16:39 CEST Updated version of record https://www.mdpi.com/2076-393X/13/8/790/pdf
Back to TopTop